N/A N=412 Training for Health Professionals In Tanzania
Health Knowledge, Attitudes, Practice · Training
Primary: Change in Sexual Health Knowledge Score From Baseline to Follow-up — 3.551; 0.086 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=106 Qubic Stim Cardiac Stimulator in China
Arrhythmia
Primary: Count of Participants With Paced Successfully by Programmed Extrastimulation (PES) — 98; 98; 100; 100 participants
Phase 2 N=26 Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.
Metastatic Melanoma
Primary: Graded Standard Systemic Toxicities (Using CTCAE Graded Toxicity Scale) by Patient — 12 participants
Phase 3 N=100 Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
Churg-Strauss Syndrome · Eosinophilic Granulomatosis With Polyangiitis
Primary: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 98; 38 Participants
Phase 3 N=92 Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach
Multiple System Atrophy
Primary: Change of Score in Motor Examination (ME) of the Unified MSA Rating Scale (UMSARS-ME) From V1 to V7. — 5.66; 6.60 score on a scale — p=0.51
Phase 1 N=23 A Relative Bioavailability and Food-Effect Study of the Fixed Dose Combination of GSK3640254 and Dolutegravir (DTG) in Healthy Participants
HIV Infections
Primary: Part 1: Area Under the Plasma Concentration-time Curve From Time 0 Extrapolated to Infinity (AUC[0-inf]) of GSK3640254 — 22.13; 21.93; 22.63 Hours*microgram per milliliter
N/A N=40 Two Year Study With Robotic-Arm Assisted Hip Surgery.
Surgery · Hip Osteoarthritis
Primary: Accuracy of Acetabular Cup Placement Manually vs. Robotic-arm Assisted - Version. — 5.95; 4.26 degrees error in anteversion
N/A N=50 FitMi Plus Home Therapy for Stroke Patients
Cerebral Stroke
Primary: Change in Motor Activity Log — 0.60; 0.40; 0.64; 0.44 score on a scale — p=0.11
N/A N=1,063 Brain Imaging Changes in Fear and Anxiety
Anxiety Disorders · Fear
Primary: Average Correlations Between Average Time Series - Left & Right Hemisphere of the Brain — 0.9; 0.92 correlation coefficient (r) — p=< 0.001
N/A N=94 Virtual Human Technology for Patients With Chronic Pain
Chronic Musculoskeletal Pain
Primary: Pain Intensity — -0.21; -0.56; -0.09 score on a scale
Phase 3 N=457 Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)
Seborrheic Dermatitis
Primary: Achievement of Success on the Investigator Global Assessment (IGA) at Week 8 — 80; 58 percentage of participants — p=<0.0001
Phase 1 N=47 This Study in Healthy Men and Women Tests Whether BI 409306 Has an Effect on the ECG (Thorough QT Study)
Healthy
Primary: Change From Baseline in QTcF at That Timepoint Between 20 Minutes to 24 Hours After Drug Administration Where the Difference of Means in QTcF Changes From Baseline…
N/A N=106 Comparing a Novel Phototherapy Kiosk to Oral Vitamin D Supplementation
Hypovitaminosis D
Primary: Serum Vitamin D Level — 30.0; 25.5 ng/mL — p=0.01
N/A N=38 Cognitive Ability Training in Seniors
Mild Cognitive Impairment
Primary: Neuropsychological Performance in Neuropsychological Test: Verbal Learning Memory Test (VLMT) — 57.2; 57.2 score on a scale — p=0.74
N/A N=200 The Wise App Trial for Improving Health Outcomes in PLWH
HIV/AIDS
Primary: Change in ART Adherence - Clever Cap — 0.385; 0.445 Times taking medication/day — p=<0.0001